FeesSafety
Pluang+

ACT Energy Technologies upgrades to OTCQX, boosting visibility for U.S. investors

Market News
23 Oct 2026
GlobeNewsWire
View Source
Bullish
ACT Energy Technologies upgrades to OTCQX, boosting visibility for U.S. investors

ACT Energy Technologies Ltd., a provider of directional drilling services in North America, has upgraded its trading status from the OTCQB Venture Market to the OTCQX Best Market. This move reflects the company's compliance with higher financial and governance standards, enhancing its visibility and credibility among U.S. investors. Trading under the symbol ACXAF, ACT Energy offers specialized drilling technology and remote operations to oil and gas companies. The upgrade signals growth potential and increased investor interest in the company within the U.S. market.

ACT Energy Technologies Ltd.'s trading upgrade on OTCQX provides context for energy sector activity. For readers following Energy-sector US stocks on Pluang as of Oct 23, 2026 17:21 WIB: out of 79 priced stocks, 51 rose and 19 fell. Notably, UGP rose 2.31% to USD 7.98 with a typical hold time of 9 days, while WMB and SU gained 2.15% and 2.05% respectively, priced at USD 72.15 and USD 79.00, with longer typical hold times of 58 and 57 days respectively and mixed Pluang order activity ratios.

More News

Zinc and tin supply shortages revive interest in historic US mining districts with new drilling results.

Zinc and tin supply shortages revive interest in historic US mining districts with new drilling results.

Global zinc supply is expected to fall short by 88,000 tonnes in 2026 amid declining mine production, while tin demand is projected to outpace supply growth through 2035. This has renewed exploration in historic polymetallic mining districts in the U...

Market News
Bullish
19 minutes ago
Avacta's AVA6103 shows promise against Enhertu-resistant tumors in early trial and preclinical data

Avacta's AVA6103 shows promise against Enhertu-resistant tumors in early trial and preclinical data

Avacta Therapeutics presented positive preclinical and early clinical data for AVA6103, a novel peptide-drug conjugate targeting FAP-positive tumors resistant to Enhertu. AVA6103 demonstrated superior tumor control and prolonged drug release in precl...

Market News
Bullish
1 hour ago
Obra Capital closes $403.6M CLO deal, pushing total CLO issuance over $2B in under two years.

Obra Capital closes $403.6M CLO deal, pushing total CLO issuance over $2B in under two years.

Obra Capital has closed its fifth Collateralized Loan Obligation (CLO) offering, raising $403.6 million. This deal brings the firm's total CLO issuance to more than $2 billion across five deals in less than two years, demonstrating strong investor co...

Company Fundamentals
Bullish
1 hour ago
Padeliporfin VTP shows promise in making unresectable pancreatic cancer operable in Phase 1 trial

Padeliporfin VTP shows promise in making unresectable pancreatic cancer operable in Phase 1 trial

ImPact Biotech reported positive early results from its Phase 1 trial of Padeliporfin VTP in patients with locally advanced, unresectable pancreatic cancer. Of 12 patients treated, 75% have undergone or are scheduled for surgery, with over half achie...

Company Fundamentals
Bullish
1 hour ago
eSoftware offers a quick diagnostic to help organizations secure sensitive files before Microsoft 365 Copilot rollout.

eSoftware offers a quick diagnostic to help organizations secure sensitive files before Microsoft 365 Copilot rollout.

eSoftware Associates has introduced a free five-minute AI readiness assessment to help regulated organizations identify and prioritize security risks related to sensitive file access in Microsoft 365 before deploying Copilot. The assessment highlight...

Others
Neutral
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App